Monday, January 10, 2011

come and grow with LVPEI.

Our Team

LVPEI NETWORK

Chair
Gullapalli N Rao

Management

Usha Gopinathan, Executive Director
Sreedevi Penmetcha, New Programs & International Liaison
Haragopala Krishna K, Finance & Accounts
Subba Rao, Finance & Accounts
Annapurna Devi, Chief Technology Officer
Sam Balasundaram, Fund Raising & Donor Relations
M Venkatesh Reddy, Trust Affairs & Chairman's Office
Ghanshyam Singh, Opticals & Opticianry
V Rajashekar, New Projects & Development
M Shoba, Audio Visual
SBN Chary, Photography
 
L V Prasad Eye Institute, Hyderabad

Director and Dr Kallam Anji Reddy Distinguished Chair of Ophthalmology
G Chandra Sekhar
Cornea & Anterior Segment
Virender S Sangwan
Prashant Garg
Pravin V Krishna
Muralidhar R
Somasheila Murthy
Varsha Rathi
Mukesh Taneja
Bhupesh Bagga
Sunita Chaurasia
Vinay S Pillai
Sayan Basu
Kunjal Sejpal
 
Bausch & Lomb Contact Lens Centre
Varsha Rathi
Preeji Shyamsunder
T Shyamsunder
D Srikanth
 
Laser Refractive Surgery Centre
Pravin V Krishna
Muralidhar R
Prashant Garg
Somasheila Murthy
Varsha Rathi
 
Ophthalmic Plastic Surgery, Orbit
& Ocular Oncology
Santosh G Honavar
Milind N Naik
Vijay Anand P Reddy
Mohammad Javed Ali

Ocular Prosthesis
Nusrat Changal
Raju Kumar

Uveitis & Ocular Immunology
Virender S Sangwan
Somasheila Murthy
Annie Mathai
Raja Narayanan
Rajeev K Reddy

Comprehensive Ophthalmology
Rohit Khanna
Bhupesh Bagga
Kunjal Sejpal
Smt. Kannuri Santhamma Centre for
Vitreo Retinal Diseases
Subhadra Jalali
Ajit B Majji
Annie Mathai
Raja Narayanan
Padmaja K Rani
Rajeev K Reddy
Chinmaya Amulyanath Sahu
 
VST Centre for Glaucoma Care
G Chandra Sekhar
B L Harsha
Anil K Mandal
Sirisha Senthil
Vanita Pathak-Ray

Jasti V Ramanamma Children’s Eye Care Centre
Anil K Mandal
Muralidhar R
Santosh G Honavar
Subhadra Jalali
Ramesh Kekunnaya
Pravin V Krishna
Padmaja K Rani
Niranjan K Pehere
 
Strabismus (Squint) / Neuro-ophthalmology
Ramesh Kekunnaya
Niranjan K Pehere

Aesthetic Facial Plastic Surgery
Milind N Naik


Internal Medicine
Archana Bhargava
Y Srinivasa Rao
Mohammad Abdul Basith

Dietician
Varsha Menon
Vision Rehabilitation Centres
Meera & L B Deshpande Centre for Sight Enhancement
Dr PRK Prasad Centre for Rehabilitation of Blind & Visually Impaired
Vijaya K Gothwal Hemalatha Arunachalam
Beula Christy Deepak K Bagga
Mahalakshmi Rebecca Sumalini
Ramayamma International  Eye Bank

Usha Gopinathan
Prashant Garg
Education Centre

Director and Distinguished Chair of Education
Prashant Garg

Administration
Shaik Yousuf Arfath

LVP-Zeiss International Academy of Advanced Ophthalmic Education
Vanita Pathak-Ray
Varsha Rathi

Bausch & Lomb School of Optometry
Principal
P K Sai Prakash
Faculty
M Srinivas
Vanita Pathak-Ray

Prof Brien Holden Eye Research Centre

Director and Distinguished Chair of Eye Research
D Balasubramanian

Jhaveri Microbiology Centre
Savitri Sharma Das
Suma Nalamada

Saroja A Rao Immunology Laboratory
Savitri Sharma Das
Suma Nalamada

Kallam Anji Reddy Molecular Genetics Laboratory
Chitra Kannabiran
Subhabrata Chakrabarti
Inderjeet Kaur

Ophthalmic Pathology Laboratory
Geeta K Vemuganti

Sudhakar & Sreekanth Ravi Stem Cell Biology Laboratory
Geeta K Vemuganti
Virender S Sangwan
Indumathi Mariappan

Visual Optics and Psychophysics Laboratory
Shrikant R Bharadwaj

Administration
Jai Ganesh
 
International Centre for Advancement of Rural Eye care (ICARE), Kismatpur Campus

Associate Director
Rohit Khanna  

Programs & Projects
Gullapalli N Rao M Srinivas
Sheela Devi Kovai Vilas
Giridhar Pyda Jachin David Williams
V Rajashekar S Krishnaiah, Biostatistician
Imtiaz Ahmed  

Administration
Babu Rao

L V Prasad Eye Institute, Bhubaneswar

Director
Taraprasad Das


 
Cornea & Anterior Segment
Sujata Das
Srikant K Sahu
 
Miriam Hyman Children's Eye Care Centre
Siddharth Kesarwani
Sanghamitra Dash
Tapas Ranjan Padhi
Suryasnata Rath
 
NTPC Centre for Diabetic Eye Diseases
Taraprasad Das
Soumyava Basu
Tapas Ranjan Padhi
 
NTPC Eye Trauma Centre
Suryasnata Rath
Soumyava Basu
Sujata Das
Tapas Ranjan Padhi
 
Administration
Bikash Chandra Mohanta
Prakash Das
Chhotan De
Raghuram Sastry

 
 
 
Glaucoma
Sanghamitra Dash
 
Ophthalmic Plastic Surgery, Orbit & Oncology
Suryasnata Rath
 
Ocular Prosthesis
Mahasweta Chowdhury
Bhaktiprada Sahoo
 
Retina & Vitreous
Soumyava Basu
Taraprasad Das
Tapas Ranjan Padhi
 
Contact Lens & Refractive Surgery
Sujata Das
Souvik Mandal
Srikant K Sahu
Mukesh K Singh
Santanu Jana
 
NTPC Centre for Sight Enhancement
A Mercyba
 
drushti daan Eye Bank *
Sujata Das
Srikant K Sahu
 
* Community Eye Bank on our campus



L V Prasad Eye Institute, Visakhapatnam

Director
Merle Fernandes
 
Cornea & Anterior Segment
Merle Fernandes
Sushmita G Shah
I S Murthy
 
Contact Lens & Refractive Surgery
Merle Fernandes
Rekha Gunturu
 
Glaucoma
P V K S Varma
 
Ophthalmic Plastic Surgery, Orbit & Ocular Oncology
 
Neuro-ophthalmology
Virender Sachdeva
Avinash Pathengay
 
Retina & Vitreous
Avinash Pathengay
Gaurav Yogesh Shah
Manmath Kumar Das
 

 
 
 
Uveitis
Avinash Pathengay
 
Nimmagadda Prasad Children's Eye Care Centre
Merle Fernandes
Virender Sachdeva
P V K S Varma
 
Strabismus
Virender Sachdeva
 
Bob Ohlson Centre for Sight Enhancement
Rekha Gunturu
 
Mohsin Eye Bank *
Merle Fernandes
* Community Eye Bank on our campus
 
Administration
Anjaneyulu
K Lokesh
D Ch Lakshmi

Ocular Prosthetic Clinic at LVPEI....

Ocular Prosthesis

L V Prasad Eye Institute is the only eye hospital in India where Ocularistry Services are integrated with the Ophthalmic Plastic Surgery division. Till date, its Ocular Prosthesis clinic, set up in 2002, has fitted over 6000 patients with artificial eyes. Patients who suffer from tumors, trauma or infections and have had their eye removed, either partially or totally, can be fitted with an artificial eye once the healing process is complete. An artificial eye can also be fitted over a shrunken, sightless eye for cosmetic purposes.
Making an artificial eye is a critical process. It requires thorough knowledge of anatomy, ophthalmology and polymer chemistry, as well as creativity and artistic talent. First, an impression of the eye socket is taken and the shape is recreated in wax. It is then inserted in the eye to assess the fit. The wax model is finally replicated in acrylic.
The artificial eye is made from medical grade polymethyl-metha-acrylate (PMMA). It is an exact replica of the companion eye - it looks natural and moves at will. Biologically inert and safe natural pigments and threads are used for the artificial eye to match the color of the natural eye. Even minute details like small red blood vessels are faithfully duplicated. The final stage is a clear coating, which helps keep the color intact.

Retinoblastoma

Retinoblastoma

Although uncommon and occurring in only 1 in 18,000 to 20,000 live births, retinoblastoma is the most common tumor of the eye and usually occurs in the first few years of a child's life and most cases (90%) occur before age 5. Although not as common, older children can get retinoblastoma too, and they usually complain of eye pain or decreased vision in the affected eye. Retinoblastoma is responsible for causing 5% of the cases of childhood blindness. There is a tumor suppressor gene on the long arm of chromosome 13 and it is the retinoblastoma gene. The presence of this gene helps to suppress retinoblastoma from forming by forming a protein that is though to help regulate cell growth. If both copies of the gene are mutated or absent, then retinoblastoma can form. In familial or genetic forms of retinoblastoma, one copy of the defective gene is usually inherited and the other one becomes mutated. In non hereditary cases of retinoblastoma, both genes become mutated.
Retinoblastoma is commonly found during routine screening in high risk children, specifically newborns that have other family members with retinoblastoma. Other infants are diagnosed when they are found to not have a red reflex (or red eye) during a routine well baby checkup or if the child's eyes appear different in a photograph. Instead, they have leukocoria (cat's eye reflex) or a white pupillary reflex. Later symptoms can include redness or inflammation of the eye, strabismus or abnormalities of the pupil.
Further evaluation and testing include an evaluation by a pediatric ophthalmologist and an ultrasound or CT scan of the eye. Other testing may also be required if it is though that the tumor has spread outside the eye.
Retinoblastoma can be either unilateral, affecting only one eye, or it can be bilateral, affecting both eyes.
Treatments depend on the size of the tumor and whether vision can be preserved, and can include laser photocoagulation or cryotherapy, external beam radiation, multi drug chemotherapy, or in some cases, surgery or enucleation (although this isn't routinely recommended anymore) if the tumor is very advanced or if vision can not be preserved. .
Outcomes are in general very good, especially if the retinoblastoma is only affecting one eye.
Children with retinoblastoma are also at risk of developing secondary malignancies, especially osteosarcoma, a malignant bone tumor that can present with pain and swelling of the affected bone or joint.


Retinoblastoma Internet Resources:

  • Retinoblastoma: from the Eye Cancer Network, an extensive review of symptoms and treatments of retinoblastoma, with pictures of leukocoria.
  • An Overview of Retinoblastoma: an overview of retinoblastoma from Cancer Net, including stages of retinoblastoma and treatments, plus genetics, causes, risk factors, and prevention.
  • The Retinoblastoma Society: A national charity offering support and information to people with retinoblastoma and their families.
  • retinoblast: Retinoblastoma discussion group for anyone to ask questions, seek advice and get opinions from other affected people and their families.
  • Children's Cancer Web Retinoblastoma page: Information about retinoblastoma, plus listings of organizations and support groups, and other resources.
  • Family Village Retinoblastoma page: where to go to chat with others about retinoblastoma, how to learn more about it, plus personal stories, web sites, and international & non-english resources.
  • Retinoblastoma An Eye Cancer: In this section of the Retinoblastoma Resource Center from the American Cancer Society, you'll find an introduction to cancer, an overview of Retinoblastoma , and related Retinoblastoma statistics.

Related Links

Sunday, January 9, 2011

History of Artificial Eyes...............................



History photo
The eye was a symbol of life to the ancient world, particularly in Egypt, where bronze and precious stone eyes were placed on the deceased. The Romans decorated statues with artificial eyes made of silver. Ambrose Paré (1510-1590), a famous French surgeon, was the first to describe the use of artificial eyes to fit an eye socket. These pieces were made of gold and silver, and two types can be distinguished: ekblephara and hypoblephara, intended to be worn in front of or under the eyelids, respectively. A hypoblephara eye was designed to be used above an atrophic eye, as enucleation was not a common practice until the middle of the 1800s.
History photo As with most things that evolved over time, it is difficult to trace the inventor of the artificial glass eye, but William Shakespeare (1564-1616) knew of its existence: Get three glass eyes;
And, like a scurvy politician, seem
To see the things thou dost not.

(King Lear to the Earl of Gloucester, Act IV, Scene 6)
Enamel prostheses (1820s-1890s) were attractive but were expensive and not very durable. The introduction of cryolite glass, made of arsenic oxide and cyolite from sodium-aluminum fluoride (Na6A2F12), produced a grayish-white color suitable for a prosthetic eye. German craftsmen are credited with this invention in 1835. To make these glass eyes, a tube of glass was heated on one end until the form of a ball was obtained. Various colors of glass were used like paintbrushes to imitate the natural color of the eye.
The glass art form flourished in France and Germany where fabricating secrets were handed down from one generation to the next. The town of Lausche, Germany, had a particularly rich history in both decorative (doll eyes, Christmas ornaments) and prosthetic arts. In the 19th century, German craftsmen (later coined "ocularists") began to tour the United States and other parts of the world, setting up for several days at a time in one city after another where they fabricated eyes and fit them to patients. Eyes were also fitted by mail order.
Stock eyes (or pre-made eyes) were also utilized. An "eye doctor" might keep hundreds of glass stock eyes in cabinets, and would fit patients with the best eye right out of the drawer.
In the United States, eyes continued to be made of glass until the onset of World War II, when German goods were limited and German glass blowers no longer toured the United States. The United States military, along with a few private practitioners, developed a technique of fabricating prostheses using oil pigments and plastics. Since World War II, plastic has become the preferred material for the artificial eye in the United States.

Virginia's History of Eye Making

In the early 1800s, most people in Virginia and in the surrounding areas relied on imported, German-made, glass (stock) artificial eyes following surgery. Patients were fit by the local oculist, who was the equivalent of today's ophthalmologist.
During the 1850s, several German-founded companies started custom-making prostheses in New York City. Craftsmen sold eyes to regional eye care practitioners, or mailed semi-custom pieces to individuals. For more custom work, an individual needed to travel to New York City or Philadelphia to have a custom prosthesis hand-blown from scratch.
In the 1920s, several of these glass eye companies started to travel to various cities, once a month, to make prostheses for patients. The New York firm of Fried and Kohler, which consisted of brothers, Irwin and Hugo Kohler, traveled to Richmond to work with Salo and Joseph Galeski of Galeski Optical.Mager and Gougelmann (also of New York City) traveled to Norfolk (working with Traylor Optical) and eventually set up satellite offices in Washington, D.C. and Baltimore, Maryland.
By the mid-1940s, glass eyes were being replaced by plastic counterparts. In Virginia, this was led by Joseph Galeski (of Richmond, Virginia),although American Optical and several military hospitals started to experiment and dispense plastic artificial eyes.
Present day ocularistry has evolved through the invention and technique of many individuals. The birth of the American Society of Ocularists (1957) and the refinement of ocular implants and surgical procedures have greatly improved the end results that ocularists can achieve.